Nephrology News

The FDA has granted Outset Medical Inc. 510(k) clearance of TabloCart with Prefiltration, an optional accessory for the Tablo Hemodialysis System, according to a press release.

Addressing disparities in standard of care in disease monitoring and perception of disease progression could improve treatment for adults with Fabry disease, according to published data.

Researchers at Brigham and Women’s Hospital developed a tool that predicts risks for moderate to severe kidney injury after treatment with the chemotherapy drug cisplatin.

Tumor necrosis factor inhibitor use was independently associated with a greater risk for progressive kidney function decline but not risk for all-cause mortality among patients with new-onset inflammatory bowel disease, according to data.

Adverse drug reactions make up a major cause of hospitalization in patients with chronic kidney disease where lower eGFR is a risk factor, according to published data.

Targeted educational and training programs may help address barriers that could limit cystatin C use in clinical practice for enhanced chronic kidney disease detection, according to published data.

BOSTON — Cardiovascular-kidney-metabolic syndrome, or CKM, is a new term endorsed by the American Heart Association that reflects the interplay of metabolic and renal conditions that drive the risk for CVD.

Healio is accepting submissions for its third annual peer-recognition program, Healio Honors.

Standard infection prevention and control procedures prevented the spread of Candida auris at a Tennessee dialysis facility despite two patients there being colonized for up to 4 months during treatment, researchers reported.